NM_176787.5:c.1646T>C
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_176787.5(PIGN):c.1646T>C(p.Leu549Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000818 in 1,589,746 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_176787.5 missense
Scores
Clinical Significance
Conservation
Publications
- multiple congenital anomalies-hypotonia-seizures syndrome 1Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, Orphanet, ClinGen, PanelApp Australia
- Fryns syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_176787.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PIGN | NM_176787.5 | MANE Select | c.1646T>C | p.Leu549Ser | missense | Exon 18 of 31 | NP_789744.1 | ||
| PIGN | NM_001438896.1 | c.1646T>C | p.Leu549Ser | missense | Exon 18 of 32 | NP_001425825.1 | |||
| PIGN | NM_012327.6 | c.1646T>C | p.Leu549Ser | missense | Exon 17 of 30 | NP_036459.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PIGN | ENST00000640252.2 | TSL:1 MANE Select | c.1646T>C | p.Leu549Ser | missense | Exon 18 of 31 | ENSP00000492233.1 | ||
| PIGN | ENST00000400334.7 | TSL:1 | c.1646T>C | p.Leu549Ser | missense | Exon 17 of 30 | ENSP00000383188.2 | ||
| PIGN | ENST00000638424.1 | TSL:5 | n.1646T>C | non_coding_transcript_exon | Exon 16 of 29 | ENSP00000491963.1 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152230Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000652 AC: 14AN: 214582 AF XY: 0.0000784 show subpopulations
GnomAD4 exome AF: 0.00000557 AC: 8AN: 1437516Hom.: 0 Cov.: 29 AF XY: 0.00000702 AC XY: 5AN XY: 712540 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152230Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74370 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.1646T>C (p.L549S) alteration is located in exon 18 (coding exon 15) of the PIGN gene. This alteration results from a T to C substitution at nucleotide position 1646, causing the leucine (L) at amino acid position 549 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Multiple congenital anomalies-hypotonia-seizures syndrome 1 Uncertain:1
This sequence change replaces leucine with serine at codon 549 of the PIGN protein (p.Leu549Ser). The leucine residue is moderately conserved and there is a large physicochemical difference between leucine and serine. This variant is present in population databases (rs769428343, ExAC 0.4%). This variant has not been reported in the literature in individuals affected with PIGN-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C25". The serine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at